The AMPK-PGC1α axis regulated by Myr emerges as a central node for counteracting dAGE-induced dysmetabolism, offering a multifaceted strategy against obesity and its complications. This evidence concerns the gene PPARGC1A and obesity due to melanocortin 4 receptor deficiency.